SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-22-000123
Filing Date
2022-07-11
Accepted
2022-07-11 06:05:13
Documents
8
Period of Report
2022-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k_071122.htm 6-K 359036
2 GRAPHIC policy_1.jpg GRAPHIC 22219
3 GRAPHIC policy_2.jpg GRAPHIC 19448
4 GRAPHIC policy_3.jpg GRAPHIC 19134
5 GRAPHIC policy_4.jpg GRAPHIC 22206
6 GRAPHIC policy_5.jpg GRAPHIC 28786
7 GRAPHIC policy_6.jpg GRAPHIC 34257
8 GRAPHIC structure.jpg GRAPHIC 355313
  Complete submission text file 0001395064-22-000123.txt   1051518
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 221075819
SIC: 2834 Pharmaceutical Preparations